Kazia Therapeutics (KZIA) Intangibles (2013 - 2025)
Kazia Therapeutics (KZIA) reported Intangibles of $713379.8 for Q4 2025, down 92.46% on a YoY basis from $9.5 million in Q4 2024, and up 2.52% quarter-over-quarter from $695840.9 in Q2 2025.
Kazia Therapeutics (KZIA) Intangibles (2013 - 2025) Analysis & Trends
Kazia Therapeutics has reported Intangibles for 11 years, with the latest figure at $713379.8 in Q4 2025.
- For the quarter ending Q4 2025, Intangibles fell 92.46% year-over-year to $713379.8; the trailing twelve-month figure through Dec 2025 stood at $713379.8 (down 92.46% YoY), and the FY2025 full-year result was $695840.9, down 93.14% from the prior year.
- Intangibles for Q4 2025 stood at $713379.8, up from $695840.9 in the prior quarter.
- The five-year high for Intangibles was $16.9 million in Q2 2021, with the low at $695840.9 in Q2 2025.
- Historically, Intangibles has averaged $10.1 million across 5 years, with a median of $11.1 million in 2023.
- Annual changes were most pronounced in 2021 — Intangibles soared 108.31% — and 2025, when it sank 93.14%.
- Kazia Therapeutics' Intangibles stood at $15.3 million in 2021, then retreated by 21.92% to $12.0 million in 2022, then declined by 11.09% to $10.6 million in 2023, then decreased by 11.04% to $9.5 million in 2024, then slumped by 92.46% to $713379.8 in 2025.
- The last three Intangibles figures came in at $713379.8 (Q4 2025), $695840.9 (Q2 2025), and $9.5 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Kazia Therapeutics | 1.70 Bn | 1.70 Bn | - | 713,379.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 713,379.83 |
| Jun 30, 2025 | 695,840.92 |
| Dec 31, 2024 | 9.46 Mn |
| Jun 30, 2024 | 10.15 Mn |
| Dec 31, 2023 | 10.63 Mn |
| Jun 30, 2023 | 11.54 Mn |
| Dec 31, 2022 | 11.96 Mn |
| Jun 30, 2022 | 13.71 Mn |
| Dec 31, 2021 | 15.32 Mn |
| Jun 30, 2021 | 16.94 Mn |
| Dec 31, 2020 | 8.67 Mn |
| Jun 30, 2020 | 8.13 Mn |
| Dec 31, 2019 | 8.85 Mn |
| Jun 30, 2019 | 9.45 Mn |
| Dec 31, 2018 | 10.07 Mn |
| Jun 30, 2018 | 11.04 Mn |
| Dec 31, 2017 | 192,188.12 |
| Jun 30, 2017 | 11.96 Mn |
| Dec 31, 2016 | 11.34 Mn |
| Jun 30, 2016 | 613,789.38 |